Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MYRIAD GENETICS INC
Report date October 24, 2025 · Filed October 24, 2025
Section 16 reporting ended · disclosed 2025-10-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,167 |
Reported balance
Holding disclosure · report date 2025-10-24 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 45,167 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2025 Filed Sep 22, 2025 20:15 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 962 | $7.77 | $7,474.74 |
DisclosureSEC source: 0001932320-25-000006 · wk-form4_1758572110.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,167 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 20:19 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 362 | $9.73 | $3,522.26 |
DisclosureSEC source: 0001932320-25-000002 · wk-form4_1743020344.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,129 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 25, 2025. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 589 | $9.98 | $5,878.22 |
DisclosureSEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 4 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,491 F4 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025. Read SEC document |
| March 24, 2025 Filed Mar 25, 2025 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 393 | $9.98 | $3,922.14 |
DisclosureSEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 3 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,080 F3 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025. Read SEC document |
| March 22, 2025 Filed Mar 25, 2025 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,135 | $10.01 | $11,361.35 |
DisclosureSEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 2 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,473 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025. Read SEC document |
| March 22, 2025 Filed Mar 25, 2025 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 428 | $10.01 | $4,284.28 |
DisclosureSEC source: 0001628280-25-014728 · wk-form4_1742933827.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,608 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025. Read SEC document |
| March 15, 2025 Filed Mar 17, 2025 20:20 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 684 | $10.07 | $6,887.88 |
DisclosureSEC source: 0001628280-25-013154 · wk-form4_1742242835.xml · nonDerivative · entry 3 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,036 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 20:20 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 855 | $10.07 | $8,609.85 |
DisclosureSEC source: 0001628280-25-013154 · wk-form4_1742242835.xml · nonDerivative · entry 2 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,720 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:20 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013154 · wk-form4_1742242835.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,575 F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 07, 2025 Filed Mar 5, 2025 00:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 3,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010140 · wk-form4_1741134714.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,575 F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025. Read SEC document |
| September 21, 2024 Filed Sep 23, 2024 20:15 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 964 | $27.64 | $26,644.96 |
DisclosureSEC source: 0001932320-24-000008 · wk-form4_1727122519.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,259 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024. Read SEC document |
| August 25, 2024 Filed Aug 26, 2024 20:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 217 | $28.12 | $6,102.04 |
DisclosureSEC source: 0001932320-24-000006 · wk-form4_1724705280.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,223 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 23, 2024. Read SEC document |
| April 06, 2024 Filed Apr 8, 2024 20:49 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 581 | $20.26 | $11,771.06 |
DisclosureSEC source: 0001932320-24-000004 · wk-form4_1712609373.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,440 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 5, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 363 | $21.98 | $7,978.74 |
DisclosureSEC source: 0001932320-24-000002 · wk-form4_1711570651.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,021 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 25, 2024. Read SEC document |
| March 24, 2024 Filed Mar 25, 2024 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 580 | $22.24 | $12,899.20 |
DisclosureSEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 3 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,384 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024. Read SEC document |
| March 24, 2024 Filed Mar 25, 2024 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 401 | $22.24 | $8,918.24 |
DisclosureSEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 2 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,964 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 363 | $22.24 | $8,073.12 |
DisclosureSEC source: 0001628280-24-012919 · wk-form4_1711398717.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,365 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-011687 · wk-form4_1710794761.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,728 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 20:33 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001932320-23-000005 · wk-form4_1695414830.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,228 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 20:10 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 218 | $17.70 | $3,858.60 |
DisclosureSEC source: 0001932320-23-000003 · wk-form4_1693253445.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,228 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2023. Read SEC document |
| March 25, 2023 Filed Mar 27, 2023 20:28 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 365 | $23.72 | $8,657.80 |
DisclosureSEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 2 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,029 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:28 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 583 | $23.72 | $13,828.76 |
DisclosureSEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 3 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,446 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:28 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 404 | $23.72 | $9,582.88 |
DisclosureSEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,394 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 20:30 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 388 | $22.91 | $8,889.08 |
DisclosureSEC source: 0001628280-23-009055 · wf-form4_167960339073835.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,798 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:29 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008317 · wf-form4_167899857206258.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,186 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 20:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 220 | $24.89 | $5,475.80 |
DisclosureSEC source: 0001628280-22-023764 · wf-form4_166154528245709.xml · nonDerivative · entry 1 Munk Natalie · CIK 0001932320 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,186 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.